Connor, Clark & Lunn Investment Management (CC&L)
ORMP icon

Connor, Clark & Lunn Investment Management (CC&L)’s Oramed Pharmaceuticals ORMP Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$136K Sell
2025
Q1 		$186K Sell
2024
Q4 		$259K Sell
2024
Q3 		$272K Buy
2022
Q1 		– Sell
2021
Q4 		$725K Buy
2021
Q3 		$568K Buy